Interview: Strategic collaborations accelerate bringing products to market

摘要

Israeli plant biotechnology company Evogene is bullish on the prospects of its subsidiaries (agrochemical-focused AgPlenus and biologicals-focused Lavie Bio) and is gearing up for a slew of product launches in the next couple of years. Ofer Haviv, the company’s CEO and president, touched upon diverse topics such as the firm’s strategies and partnerships, and his thoughts on GM crops and precision agriculture in a candid conversation with Akashpratim Mukhopadhyay.